Responsive Image

 

 

Responsive Image

Cardiología clínica

Líneas de investigación

Arritmias-estimulación cardíaca.
Cardiopatía isquémica aguda–hemodinámica.
Insuficiencia cardíaca-cardiología clínica.

 

Actividades del grupo

Arritmias-estimulacion cardíaca

La sección de arritmias del servicio de cardiología fue pionera en Euskadi y de las primeras del estado en el tratamiento de las arritmias mediante estudio electrofisiológico desde principio de los años 90 desarrollando desde entonces una actividad docente en este campo. Centro de referencia actualmente para estudios electrofisiológicos para la OSI Bilbao y Galdakao con múltiples publicaciones de los miembros de la sección a lo largo de su historia.

La fibrilación auricular es hoy en día la arritmia más frecuente en nuestra población y esta implicados en diferentes ensayos clínicos para optimizar los procedimientos de ablación y el manejo anticoagulante más apropiado.

La sección está implicada en la implantación y seguimiento de marcapasos y desfibriladores, así como en el desarrollo tecnológico de estos dispositivos colaborando con los diferentes fabricantes.

Cardiopatía isquémica aguda–hemodinámica

Pionero en la técnica y el primer hospital de Euskadi que implantó la angioplastia primaria el tratamiento del infarto agudo de miocardio técnica en la que sigue siendo centro de referencia para el tratamiento del infarto las 24 horas para la OSI Bilbao y Galdakao. La unidad coronaria integrada con la sección de Hemodinámica permite un tratamiento optimizado del síndrome coronario agudo.

Insuficiencia cardíaca-cardiología clínica

La creación de la unidad de insuficiencia cardiaca permite un seguimiento de pacientes de especial riesgo, pioneros en el desarrollo de la telemonitorización de estos pacientes han publicado diferentes estudios demostrando la utilidad de este manejo. Participa en múltiples estudios enfocados al desarrollo de nuevos fármacos. Para el diagnóstico, tratamiento y seguimiento del paciente cardiológico mantiene las consultas de proximidad en 5 centros de salud de Bilbao y se han organizado consultas específicas de: Cardiooncología, Cardiopatías congénitas del adulto, Cardiopatías familiares, Hipertensión pulmonar, desarrollando todas ellas ensayos clínicos y proyectos de investigación que permitirán el mejor conocimiento y tratamiento de las diferentes cardiopatías.

Coordinador/a del grupo



Miembros del grupo

  Abel Andrés Morist
 
 
  María Fe Arcocha Torres
 
 
  Amaya Arregui López
 
 
  Haritz Arrizabalaga Aróstegi
 
 
  Ane Elorriaga Madariaga
 
 
  Vanessa Escolar Pérez
 
 
  Alain García Olea
 
 
  Larraitz Gaztañaga Arantzamendi
 
 
  Alain Laskibar Asua
 
 
  Ainara Lozano Bahamonde
 
 
  Jesús Daniel Martinez Alday
 
 
  Jose Miguel Ormaetxe Merodio
 
 
  Iñigo Pereiro Lili
 
 
  Ainhoa Rubio Ereño
 
 
  Estíbaliz Zamarreño Golvano
 
 
  Jesús Roberto Sáez Moreno
 
 
  Amaia Núñez Iñiguez
 
 
  Andrés Ignacio Bodegas Cañas
 
 
  Elena Amaia Lopez Etxebarria
 
 
  Inmaculada Arranz Cengotita
 
 
  Iñigo Sainz Godoy
 
 
  Jorge Díaz Calvo
 
  José Felix Larrea Egurbide
 
 
  José Ignacio Arana Aramburu
 
 
  Roberto Blanco Mata
 
 
  Roberto Blanco Mata
 
 
  Ángela Cacicedo Fernández De Bobadilla
 
 
  María Ángeles Eneriz Pérez
 
 
  José González Ruiz
 
 
  Uxue Idiazabal Rodríguez
 
 
  Gonzalo Navarrete Lara
 
 
  José Juan Onaindia Gandarias
 
 
  Garazi Oria González
 
 
  Olga Quintana Raczka
 
 
  Alaitz Romero Pereiro
 
 
  José Ramón Rumoroso Cuevas
 
 
  Mario Sadaba Sagredo
 
 
  Alberto Salcedo Arruti
 
 
  Iñigo Sanz Ortega
 
 
  Asier Subinas Elorriaga
 
 
  Alberto Ullate De La Torre
 
 
  Alazne Urkullu Naveda
 
 
  Sonia Velasco Del Castillo
 
 
  German Zugazabeitia Irazabal
 
 
  Javier Zumalde Otegui
 
 
  Jon Ander Puerto Sánchez
 
 
  Oleger Pau Casas
 
 

Publicaciones del grupo

Minguito Carazo C, Rodriguez Manero M, Martinez Alday J, Luis Martinez Sande J, Gonzalez Melchor L, Ramon Gonzalez Juanatey J. Endocardial ganglionated plexi ablation in a patient with cardioinhibitory carotid sinus syndrome. Rev Esp Cardiol. 2022. DOI:10.1016/j.rec.2022.04.015.

Valles E, Jimenez J, Marti Almor J, Toquero J, Miguel Ormaetxe J, Barrera A, et al. Cryoballoon Ablation for Persistent and Paroxysmal Atrial Fibrillation: Procedural Differences and Results from the Spanish Registry (RECABA). J Clin Med. 2022; 11(5). DOI:10.3390/jcm11051166.

Maurovich Horvat P, Bosserdt M, Kofoed KF, Rieckmann N, Benedek T, Donnelly P, et al. CT or Invasive Coronary Angiography in Stable Chest Pain. N Engl J Med. 2022; 386(17): 1591-1602. DOI:10.1056/NEJMoa2200963.

Lorenzo Ruiz I, Gaztanaga Arantzamendi L, Marichalar Mendia X. Spanish Rhythm Association member ' s perspectives on cardiac implantable electronic device reuse in low- and middle-income countries. J Interv Card Electrophysiol. 2022. DOI:10.1007/s10840-022-01304-y.

Lozano I, Hernandez JMD, de Prado AP, Rumoroso JR, del Blanco BG. Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention Only These 2 Options?. JACC-Cardiovasc Interv. 2022; 15(8): 902-903. DOI:10.1016/j.jcin.2022.02.042.

de Frutos F, Ochoa JP, Navarro Penalver M, Baas A, Bjerre JV, Zorio E, et al. Natural History of MYH7-related Dilated Cardiomyopathy. J Am Coll Cardiol. 2022; 80(15): 1447-1461. DOI:10.1016/j.jacc.2022.07.023.

Ruiz IL, Arantzamendi LG, Mendia XM, Zeballos RM, Diaz LA. Patients' opinions on cardiac implantable electronic device reuse in Bolivia. J Interv Card Electrophysiol. 2022. DOI:10.1007/s10840-022-01375-x.

Goena C, Arana X, Villanueva I, Solla I, Rengel A, Armengou A, et al. Predictor score of diagnosis of cardiac transthyretin amyloidosis. Eur J Heart Fail. 2022; 24: 87-87

Ruiz IL, Arostegi HA, Atucha AF. Battery life of cardiac implantable electronic devices explanted in funeral homes: a potential resource for underserved nations. Expert Rev Med Devices. 2022; 19(9): 733-737. DOI:10.1080/17434440.2022.2130757.

David Dobarro D, Tobar J, Sagasti I, Rodriguez M, Escolar V, Abecia A, et al. Impact of heart failure unit complexity in the treatment with intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: Insights from the LEVO-D Registry. Eur J Heart Fail. 2022; 24: 122-123

de Juan Baguda J, Gavira Gomez JJ, Pachon Iglesias M, Cozar Leon R, Escolar Perez V, Gonzalez Fernandez O, et al. Remote heart failure management using the HeartLogic algorithm. RE-HEART registry. Rev Esp Cardiol. 2022; 75(9): 709-716. DOI:10.1016/j.rec.2021.09.015.

Moreno R, Diez J, Diarte J, Salinas P, de la Torre Hernandez JM, Andres Cordon JF et al. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic. Cardiovasc Diabetol. 2021; 20(1). DOI:10.1186/s12933-021-01261-2.

Rodriguez Leor O, Cid Alvarez B, de Prado AP, Rossello X, Ojeda S, Serrador A et al. In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients. EuroIntervention. 2021; 16(17). DOI:10.4244/EIJ-D-20-00935.

Akhtar MM, Lorenzini M, Pavlou M, Ochoa JP, O'Mahony C, Restrepo Cordoba MA et al. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure. JAMA Cardiol. 2021; 6(8): 891-901. DOI:10.1001/jamacardio.2021.1106.

Ferrero Osorio A, Cozar R, Garcia Alberola A, Valles E, Barrera A, Toquero J et al. Primary results of the Spanish Cryoballoon Ablation Registry: acute and long-term outcomes of the RECABA study. Sci Rep. 2021; 11(1). DOI:10.1038/s41598-021-96655-3.

Olea AG, Merodio J, Salazar AA, Gonzalez ID, De La Prieta IF, Rada MM et al. The role of congestive heart failure at atrial fibrillation onset in the data entry errors of electronic health records. Eur J Heart Fail. 2021; 23: 303-304

Olea AG, Acosta MJ, Gonzalez ID, Zapirain MBG, De La Prieta IF, Rada MM et al. Electronic health records features associated to coronary artery disease in patients with chest pain. Eur Heart J. 2021; 42: 1151-1151

Idiazabal U, Rodriguez AR, Lili IP, Gonzalez ID, Salazar AA, De Luis EA et al. Differences of gastrointestinal bleeding after percutaneous coronary intervention with stent implantation among the different dual anti platelet therapies. Eur Heart J. 2021; 42: 3001-3001

Delgado Arana JR, Rumoroso JR, Regueiro A, Martin Moreiras J, Minana G, Mohandes M et al. Plaque modification in calcified chronic total occlusions: the PLACCTON study. Rev Esp Cardiol (Engl Ed). 2021; 75(3). DOI:10.1016/j.rec.2021.06.011.

Hernandez JMDT, Otaegui I, Subinas A, Gomez Menchero A, Moreno R, Rondan J et al. First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study. Cardiovasc Revascularization Med. 2021; 32: 18-24. DOI:10.1016/j.carrev.2020.12.025.

McLean KA, Kamarajah SK, Chaudhry D, Gujjuri RR, Raubenheimer K, Trout I et al. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. Br J Surg. 2021; 108(12): 1448-1464. DOI:10.1093/bjs/znab336.

Vives CG, Rodriguez Sanchez I, Rekondo J, Solla I, Robledo M, Nunez Iniguez A et al. Impact of genetic testing on the management in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail. 2021; 23: 255-255

De Rubeis G, Napp AE, Schlattmann P, Geleijns J, Laule M, Dreger H, et al. Pilot study of the multicentre DISCHARGE Trial: image quality and protocol adherence results of computed tomography and invasive coronary angiography. Eur Radiol. 2020; 30(4): 1997-2009. DOI:10.1007/s00330-019-06522-z.

Barón Esquivias G, Moya Mitjans A, Martinez Alday J, Ruiz Granell R, Lacunza Ruiz J, Garcia Civera R, et al. Impact of dual-chamber pacing with closed loop stimulation on quality of life in patients with recurrent reflex vasovagal syncope: results of the SPAIN study. Europace. 2020; 22(2): 314-319. DOI:10.1093/europace/euz294.

de la Torre Hernández JM, Garcia Camarero T, Lozano Ruiz Poveda F, Urbano Carrillo CA, Sánchez Pérez I, Cano García M, et al. Angiography and optical coherence tomography assessment of the drug-coated balloon ESSENTIAL for the treatment of in-stent restenosis. Cardiovasc Revascularization Med. 2020; 21(4): 508-513. DOI:10.1016/j.carrev.2019.07.021.

Sánchez R, Vañó E, Fernández Soto JM, Ten JI, Escaned J, Delgado C, et al. Updating national diagnostic reference levels for interventional cardiology and methodological aspects. Phys Medica. 2020; 70: 169-175. DOI:10.1016/j.ejmp.2020.01.014.

Mateos Gaitan R, Vicent L, Rodriguez Queralto O, Lopez Sa E, Elorriaga A, Pastor G, et al. Dexmedetomidine in medical cardiac intensive care units. Data from a multicenter prospective registry. Int J Cardiol. 2020; 310: 162-166. DOI:10.1016/j.ijcard.2020.04.002.

Feger S, Ibes P, Napp AE, Lembcke A, Laule M, Dreger H, et al. Clinical pre-test probability for obstructive coronary artery disease: insights from the European DISCHARGE pilot study. Eur Radiol. 2020; 31(3): 1471-1481. DOI:10.1007/s00330-020-07175-z.

Fernandez Berges D, Degano IR, Fernandez RG, Subirana I, Vila J, Jimenez Navarro M, et al. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction. Open Heart. 2020; 7(2). DOI:10.1136/openhrt-2019-001169.

Rieckmann N, Neumann K, Feger S, Ibes P, Napp A, Preuss D, et al. Health-related qualify of life, angina type and coronary artery disease in patients with stable chest pain (vol 18, 205, 2020). Health Qual Life Outcomes. 2020; 18(1). DOI:10.1186/s12955-020-01443-8.

Lili IP, Bahamonde AL, Ibarrondo NG. [Prothrombosis in times of COVID-19]. Rev Esp Cardiol. 2020; 73(12): 1087-1089. DOI:10.1016/j.recesp.2020.08.013.

Rodriguez Leor O, Cid Alvarez B, de Prado AP, Rossello X, Ojeda S, Serrador A, et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol. 2020; 73(12): 994-1002. DOI:10.1016/j.recesp.2020.07.033.

COVIDSurg C. Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans. Br J Surg. 2020; 107(11): 1440-1449. DOI:10.1002/bjs.11746.

Sádaba Sagredo M, Subinas Elorriaga A, Mañas Alonso L, Benegas Aróstegui A, Puerta Seren L, Rumoroso Cuevas JR. Retrograde approach for a failed antegrade PCI. Watch out the back door. Cardiovasc Revascularization Med. 2020; 21(11): 86-90. DOI:10.1016/j.carrev.2019.07.015.

Lozano Í, Vaquerizo B, Rumoroso JR, Mohandes M. Scientific evidence and expert opinion. Why is TAVI different?. Rev Esp Cardiol (Engl Ed). 2020; 73(5): 431-432. DOI:10.1016/j.rec.2019.12.014.

Chasco L, Ballaz A, Oribe MA, Artaraz A, Aramburu A, Velasco S, et al. Thrombus in transit. Arch Bronconeumol. 2020; 56(8): 537-539. DOI:10.1016/j.arbres.2020.04.007.

Jurado Roman A, Rodriguez O, Amat I, Romani SA, Garcia Touchard A, Cruz Gonzalez I, et al. Clinical outcomes after implantation of polyurethane-covered cobalt-chromium stents. Insights from the Papyrus-Spain registry. Cardiovasc Revascularization Med. 2020; 29: 22-28. DOI:10.1016/j.carrev.2020.08.017.

Murra C, Calleros JH, Uscanga L, Soriano A, Rumoroso A, Estrada P, et al. LOOKING FOR A SUBROGATE BIOMARKER OF NUTRITIONAL IMPAIRMENT IN PATIENTS WITH CHRONIC PANCREATITIS. IS SARCOPENIA BY CT THE ANSWER?. Gastroenterology. 2020; 158(6): 343-344

Rodriguez Leor O, Cid Alvarez B, Perez de Prado A, Rossello X, Serrador A, Lopez Palop R, et al. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience. Rev Esp Cardiol (Engl Ed). 2020; 73(12): 994-1002. DOI:10.1016/j.rec.2020.08.002.

Alfonso F, Cuesta J, Garcia Del Blanco B, Bosa F, Perez de Prado A, Masotti M, et al. Scoring balloon predilation before bioresorbable vascular scaffold implantation in patients with in-stent restenosis: the RIBS VI 'scoring' study. Coronary Artery Disease. 2020. DOI:10.1097/MCA.0000000000000904.

Moreno R, Diez J, Diarte J, Macaya F, de la Torrre Hernandez J, Rodriguez Leor O, et al. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak. Catheter Cardiovasc Interv. 2020; 97(5): 927-937. DOI:10.1002/ccd.29433.

Lozano Bahamonde A, Escolar Pérez V, Echebarria Chousa A, Azcona Lucio A, Alfambra Vicente S, Rodríguez B. Subcutaneous Furosemide in Patients With Refractory Heart Failure. Rev Esp Cardiol. 2019; 72(6): 500-502. DOI:10.1016/j.recesp.2018.04.031.

Lacunza Ruiz FJ, Moya Mitjans A, Martinez Alday J, Baron Esquivias G, Ruiz Granell R, Garcia Alberola A, et al. Diagnostic yield of the implantable loop recorder in octogenarians. Eur Geriatr Med. 2019; 10(1): 129-133. DOI:10.1007/s41999-018-0128-1.

Lozano Bahamonde A, Escolar Pérez V, Echebarria Chousa A, Azcona Lucio A, Alfambra Vicente S, Rodríguez B. Subcutaneous Furosemide in Patients With Refractory Heart Failure. Rev Esp Cardiol. 2019; 72(6): 500-502. DOI:10.1016/j.rec.2018.06.012.

Cano Ó, Bellver A, Fontenla A, Villuendas R, Peñafiel P, Francisco Pascual J, et al. Spanish results of the Second European Cardiac Resynchronization Therapy Survey (CRT-Survey II). Rev Esp Cardiol (Engl Ed). 2019; 72(12): 1020-1030. DOI:10.1016/j.rec.2019.02.003.

Goena C, Natividad R, Rilo I, Gomez C, Perez De Nanclares M, Lozano A, et al. Sacubitril/Valsartan and SGLT2i: a safe combination?. Eur J Heart Fail. 2019; 21: 141-141

Goena C, Escolar V, Laskibar A, Gomez C, Natividad R, Romero A, et al. Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment. Eur J Heart Fail. 2019; 21: 138-138

Goena C, Gomez C, Natividad R, Lozano A, Escolar V, Laskibar A, et al. Reduction of loop diuretic requirements in HFrEF patients treated with Sacubitril/Valsartan. Eur J Heart Fail. 2019; 21: 412-413

Escolar Perez V, Lozano A, Larburu N, Artola G, Alvarez R, Juez B, et al. Impact of environmental factors on heart failure decompensations. Eur J Heart Fail. 2019; 21: 8-8

Gaztanaga Arantzamendi L, Asla Ormaza CC, Zamarreno Golvano E, Elorriaga Madariaga A, Arregui Lopez A, Andres Morist A, et al. Familial cardiomyopathy with a high risk of sudden cardiac death. Eur J Heart Fail. 2019; 21: 151-151

Bravo Martinez I, Elorriaga A, Arregui A, Aurrekoetxea G, Mendoza P, Asla C, et al. Pulmonary edema following acute ischemic stroke. Eur J Heart Fail. 2019; 21: 156-156

Aurrekoetxea Bajeneta GG, Mendoza Cuartero PM, Bravo Martinez I, Asla Ormaza C, Castellanos Alcalde M, Andres Morist A, et al. Myocarditis as a cause of reversible dilated cardiomyopathy. Eur J Heart Fail. 2019; 21: 158-158

Escolar Perez VV, Lozano A, Larburu N, Kerexeta J, Artetxe A, Artola G, et al. Prediction of heart failure decompensations using artificial intelligence techniques. Eur J Heart Fail. 2019; 21: 220-220

Escolar Perez VV, Lozano A, Echebarria A, Azcona A. Initial experience of a nursing consultation in the uptitration of neurohumoral treatment in patientes with heart failure and reduced ejection fraction. Eur J Heart Fail. 2019; 21: 239-239

Codina M, Ramirez Escudero G, Garcia Ibarrondo N, Manzanal Rey A, Bravo Martinez I, Aurrekoetxea Bajeneta G, et al. Heart failure and tachycardiomyopathy in a patient taking ibrutinib: a novel tyrosine kinase inhibitor. Eur J Heart Fail. 2019; 21: 303-303

Arregui Lopez A, Elorriaga Madariaga A, Andres Morist A, Elizondo Rua IM, Bravo Martinez I, Aurrekoetxea Bajeneta G, et al. A case of complicated acute aortic dissection. Eur J Heart Fail. 2019; 21: 490-490

Illingworth L, Fox KA, Kakkar AK, Fitzmaurice DA, Goto S, Hacke W, et al. Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation A Report From the GARFIELD-AF Registry. JAMA Cardiol. 2019; 4(6): 526-548. DOI:10.1001/jamacardio.2018.4729.

Bassand J, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox KA, et al. Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Results From the GARFIELD-AF Registry. Circulation. 2019; 139(6): 787-798. DOI:10.1161/CIRCULATIONAHA.118.035012.

Goto S, Angchaisuksiri P, Bassand J, Camm AJ, Dominguez H, Illingworth L, et al. Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD-AF Registry. J Am Heart Assoc. 2019; 8(3). DOI:10.1161/JAHA.118.010510.

Haas S, Camm AJ, Bassand J, Mantovani LG, Misselwitz F, Ragy HI, et al. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. Am Heart J. 2019; 213: 35-46. DOI:10.1016/j.ahj.2019.03.013.

Wollaert B, Veryoort G, Verstraete S, Voet J, Hermans K, Heyse A, et al. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry. ACTA CARDIOL. 2019; 74(4): 309-318. DOI:10.1080/00015385.2018.1494089.

Etoh T, Katsuda Y, Suetsugu T, Kumeda K, Sakuma I, Eshima K, et al. Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF -. Circ J. 2019; 83(1): 67-67. DOI:10.1253/circj.CJ-18-0655.

Martinez Alday JD, Arcocha Torres MF, Gaztañaga Arantzamendi L, Zamarreño Golvano E, Ormaetxe Merodio JM. When Less Is Equal to More. JACC Clin Electrophysiol. 2019; 5(11): 1361-1362. DOI:10.1016/j.jacep.2019.07.019.

Escolar V, Lozano A, Larburu N, Kerexeta J, Álvarez R, Juez B, et al. Impact of environmental factors on heart failure decompensations. ESC Heart Fail. 2019; 6(6): 1226-1232. DOI:10.1002/ehf2.12506.

Martinez Alday JD, Arcocha Torres MF, Gaztañaga Arantzamendi L, Zamarreño Golvano E, Ormaetxe Merodio JM. Pulmonic Valve Closure Artifact During Right Ventricular Outflow Tract Mapping. JACC Clin Electrophysiol. 2019; 5(9): 1098-1099. DOI:10.1016/j.jacep.2019.06.013.

Baron Esquivias G, Morillo CM, Moya AM, Martinez Alday JD, Ruiz Granell R, Lacunza JD, et al. Impact of dual-chamber pacing with closed loop stimulation on quality of life in patients with recurrent reflex vasovagal syncope: results from the SPAIN study. Eur Heart J. 2019; 40(1): 1270-1270

Akhtar M, Rangel Sousa D, Palomino Doza J, Achaga XA, Bilinska Z, Golvano EZ, et al. Predictors of adverse cardiovascular events in patients with truncating variants in the filamin c (flnc) gene. Eur Heart J. 2019; 40: 3103-3103

de la Torre Hernández JM, Brugaletta S, Gómez Hospital JA, Baz JA, Pérez de Prado A, López Palop R, et al. Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty. Rev Esp Cardiol. 2019; 72(12): 1005-1011. DOI:10.1016/j.recesp.2018.08.015.

de la Torre Hernández JM, Brugaletta S, Gómez Hospital JA, Baz JA, Pérez de Prado A, López Palop R, et al. Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty. Rev Esp Cardiol (Engl Ed). 2019; 72(12): 1005-1011. DOI:10.1016/j.rec.2018.09.001.

Rodriguez Sanchez I, Onaindia JJ, Velasco S, Aguirre U, Capelastegui A, Astigarraga E, et al. Association of late gadolinium enhancement with prognosis and sudden cardiac death risk in non-ischemic dilated cardiomyopathy. Eur Heart J. 2019; 40(1): 589-589

Tesis del grupo

Autor/a: Larraitz Gaztañaga Arantzamendi. Título: Resultados de un primer procedimiento de crioablación como tratamiento de la fibrilación auricular . Directores: Dra. Clara Jose Miguel Ormaetxe.

© 2022 IIS Biocruces Bizkaia